Competitor Landscape: Idiopathic Pulmonary Fibrosis (IPF)

Publisher Name :
Date: 31-Oct-2018
No. of pages: 36

Competitor Landscape: Idiopathic Pulmonary Fibrosis (IPF)

Summary

Sociable Pharma's ‘Treatment Landscape' contains evaluations of ongoing development activities within the Idiopathic Pulmonary Fibrosis (IPF) market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher -

- Executive Summary: Contains analysis of key market events that have occurred during the previous month and which have impacted Sociable Pharma's view of the disease landscape

- Landscape Updates: ‘Order of Entry' analysis, detailing timeline forecasts for each drug in Phase II development or higher; Timeline forecasts for each approved product's lifecycle management initiatives; ‘Market Entry' & ‘Direction of Travel' positioning analysis for pipeline & currently approved therapies

- Pipeline Landscape: An overview of pipeline candidates, containing snapshots of current development status; Expected drug-specific events & milestones until YE 2019

- Approved Product Landscape: An overview of pipeline candidates, containing snapshots of current development status; Expected drug-specific events & milestones until YE 2019

Key Highlights

- Development of PBI-4050 is expected to be delayed, due to Prometic's need for financing, potentially losing its first mover position vs. FibroGen & Galapagos, which have already announced the timeline for their respective Phase III trials

- FibroGen's pamrevlumab is expected to be the second novel candidate to achieve approval in IPF (pending successful Phase III trials), and its approval could be accelerated due to the fast track designation in the US

- Promedior's PRM-151 is expected to be the third novel therapy to be approved in IPF, however, Promedior did not provide a clear timeline for Phase III trial initiation, suggesting a potential delay in its development.

Scope

- The briefing is based on Sociable Pharma's analysis of clinical trial data from company announcements (press releases, earnings calls) and clinical trial databases (clinicaltrials.gov)

- Sociable Pharma applies disease & drug specific assumptions in order to forecast US & EU approvals for drugs in Phase II development, or higher - these are outlined in the report Appendix

- Forecasts are presented in pipeline forecast figures & detailed tables

- ‘Market Entry' & ‘Direction of Travel' positioning analysis for pipeline & currently approved therapies is also provided.

Reasons to buy

- Provides details on forecast US & EU approvals for pipeline drugs in Phase II development or higher

- Includes potential positioning strategies that companies may adopt for their novel assets once they are approved & launched in the market

- Reviews ongoing lifecycle management strategies for existing players in the market

- A detailed methodology allows you to understand the forecast assumptions made, enabling cross comparison with your own internal forecasts.

Competitor Landscape: Idiopathic Pulmonary Fibrosis (IPF)

Table of Contents
Introduction to Sociable Pharma's IPF ‘Competitor Landscape'
Executive Summary
Key Events & Landscape Updates
Landscape Updates
Pipeline Candidate Order of Entry
Approved Product Lifecycle Development
Pipeline Landscape
Pipeline Summary
Approved Product Development Landscape
Approved Product Summary
Appendix
  • Global Respiratory drugs Market Research Report 2020
    Published: 26-Mar-2020        Price: US 4350 Onwards        Pages: 91
    The global Respiratory drugs market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Respiratory drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Respiratory drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions:......
  • Global Ambroxol Market Status and Future Forecast 2015-2025
    Published: 26-Mar-2020        Price: US 4500 Onwards        Pages: 113
    Summary The report forecast globalAmbroxol market to grow to reach xxx Million USD in 2020 withA CAGR of xx% during the period 2020-2025. The report offers detailed coverage ofAmbroxol industryAnd main market trends. The market research includes historicalAnd forecast market data, demand,Application details, price trends,And company shares of the leadingAmbroxol by geography. The report splits the market size, by volumeAnd value, on the basis ofApplication typeAnd g......
  • Global Ambroxol Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 13-Mar-2020        Price: US 3480 Onwards        Pages: 104
    Market Overview The global Ambroxol market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ambroxol market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic......
  • Global Ambroxol Market Research Report 2020
    Published: 13-Mar-2020        Price: US 2900 Onwards        Pages: 115
    The global Ambroxol market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Ambroxol volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Ambroxol market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Chi......
  • Seasonal Allergic Rhinitis Global Clinical Trials Review, H1, 2020
    Published: 12-Mar-2020        Price: US 2500 Onwards        Pages: 382
    Seasonal Allergic Rhinitis Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, "Seasonal Allergic Rhinitis Global Clinical Trials Review, H1, 2020" provides an overview of Seasonal Allergic Rhinitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Seasonal Allergic Rhinitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ......
  • Bovine Respiratory Disease Treatment Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 08-Mar-2020        Price: US 3000 Onwards        Pages: 145
    Bovine Respiratory Disease Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Bovine Respiratory Disease Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Bovine Respiratory Disease Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-d......
  • Global Carbocisteine Market Status and Future Forecast 2015-2025
    Published: 07-Mar-2020        Price: US 4500 Onwards        Pages: 138
    Summary Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. The report forecast global Carbocisteine market to grow to reach xxx Mi......
  • Global Carbocisteine Market Research Report 2015-2025
    Published: 06-Mar-2020        Price: US 1800 Onwards        Pages: 89
    Summary Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. The global Carbocisteine market will reach xxx Million USD in 2020 with......
  • Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2020
    Published: 04-Mar-2020        Price: US 2500 Onwards        Pages: 86
    Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, "Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2020" provides an overview of Neonatal Respiratory Distress Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Neonatal Respiratory Distress Syndrome. Report includes an overview of trial numbers and their average enrollme......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs